Cell Reports (Feb 2023)

Circadian regulator CLOCK promotes tumor angiogenesis in glioblastoma

  • Lizhi Pang,
  • Madeline Dunterman,
  • Wenjing Xuan,
  • Annette Gonzalez,
  • Yiyun Lin,
  • Wen-Hao Hsu,
  • Fatima Khan,
  • Robert S. Hagan,
  • William A. Muller,
  • Amy B. Heimberger,
  • Peiwen Chen

Journal volume & issue
Vol. 42, no. 2
p. 112127

Abstract

Read online

Summary: Glioblastoma (GBM) is one of the most aggressive tumors in the adult central nervous system. We previously revealed that circadian regulation of glioma stem cells (GSCs) affects GBM hallmarks of immunosuppression and GSC maintenance in a paracrine and autocrine manner. Here, we expand the mechanism involved in angiogenesis, another critical GBM hallmark, as a potential basis underlying CLOCK’s pro-tumor effect in GBM. Mechanistically, CLOCK-directed olfactomedin like 3 (OLFML3) expression results in hypoxia-inducible factor 1-alpha (HIF1α)-mediated transcriptional upregulation of periostin (POSTN). As a result, secreted POSTN promotes tumor angiogenesis via activation of the TANK-binding kinase 1 (TBK1) signaling in endothelial cells. In GBM mouse and patient-derived xenograft models, blockade of the CLOCK-directed POSTN-TBK1 axis inhibits tumor progression and angiogenesis. Thus, the CLOCK-POSTN-TBK1 circuit coordinates a key tumor-endothelial cell interaction and represents an actionable therapeutic target for GBM.

Keywords